Use your < > keys to browse more stories

Xiaomi Says Monthly Income Now Exceeds $158 million

xiaomiIt’s hard to believe that less than a year ago, Xiaomi hadn’t even released its phone onto the market. Now, versions of its handset are available for multiple carriers, heavily promoted in China Unicom stores, and selling out online in minutes whenever a new sale opens. Perhaps it’s no surprise, then, that the company says it’s now taking in more than 1 billion RMB ($158 million) in revenue each month. It is also shipping more than 500,000 units of its M1 handset each month.

The company has also grown substantially, now boasting over 1,000 employees, including more than 400 people on its service team. Xiaomi was criticized by some for having substandard after-sales service after its handset was released, and clearly the company is working hard to ensure that if nothing else, the service team is not understaffed. It is apparently dealing with an average of 150 customer problems per day at present.

In addition to building and training its young customer service team — most of the service staff has been at the company only a few months — Xiaomi is working on its next generation handset and building and optimizing various internal apps, like its Miliao chat platform.

It’s worth noting that Xiaomi is not a public company and isn’t required to publicly disclose any of this information; it was all surrendered voluntarily as part of an “Open Day” promotional event. That’s pretty cool; we like numbers and openness, so we hope other companies may follow Xiaomi’s lead here. Cough, cough, eedoo, cough.

[via Sina Tech]

Tags:

 

Did you enjoy this article? Consider becoming a voluntary subscriber to Tech in Asia. Although our site is free and it will stay that way, subscribing is a great way to show your support. Plus, subscribing also gets you exclusive access to our weekly subscribers-only newsletter, a roundup of each week’s most interesting Asia tech news from all over the web. You can read our ethics statement on subscriptions here.